BMJ Sexual & Reproductive Health | BMJ Sexual & Reproductive Health is a multiprofessional journal that promotes sexual and reproductive health and wellbeing, and best contraceptive practice, worldwide.

Intro Widget

BMJ Sexual & Reproductive Health is a multiprofessional journal that promotes sexual and reproductive health and wellbeing, and best contraceptive practice, worldwide. It publishes research, debate and comment to inform policy and practice, and recognises the importance of professional-patient partnership. It is the official journal of the Faculty of Sexual and Reproductive Healthcare.

You can follow the journal via Twitter, Facebook and the blog. Occasional free audio podcasts are also published.

Editor-in-Chief: Sandy Goldbeck-Wood, Specialist in Psychosexual Medicine, Cambridge, UK
Editorial team

Note: The journal was previously published as Journal of Family Planning and Reproductive Health Care.

Impact Factor: 2.027

Authors

BMJ Sexual & Reproductive Health considers unsolicited submissions of a wide range of article types, including research, systematic and narrative review articles, personal views and editorials. Responses to published work are also encouraged.

The Author Information section provides general guidelines and requirements for specific article types. Information is also provided on editorial policies and optional open access fees.

All manuscripts should be submitted online.

Author information

Submit a paper

Intro Widget

Latest Articles

Research:

Removal of intrauterine contraception with non-visible threads: a case series

Research:

Menstrual restriction prevalence and association with intimate partner violence among Nepali women

Research:

A formative evaluation of online information to support abortion access in England, Northern Ireland and the Republic of Ireland

Better way of working:

Implementing integrated sexual and reproductive healthcare in a large sexual health service in England: challenges and opportunities for the provider

Research:

Impact of a case management programme for women seeking later second-trimester abortion: the case of the Massachusetts Access Program

Most Read Articles

Letter to the Editor:

Infection 10 months after insertion of Nexplanon implant

Review:

The 7-day contraceptive hormone-free interval should be consigned to history

Research:

A formative evaluation of online information to support abortion access in England, Northern Ireland and the Republic of Ireland

Editorial:

Early medical abortion: best practice now lawful in Scotland and Wales but not available to women in England

Research:

Second-trimester medication abortion outside the clinic setting: an analysis of electronic client records from a safe abortion hotline in Indonesia

Related Journals

Editor’s Choice

Research:

Initiating intramuscular depot medroxyprogesterone acetate 24–48 hours after mifepristone administration does not affect success of early medical abortion

Review:

The 7-day contraceptive hormone-free interval should be consigned to history

Review:

Assessing the impact of TRAP laws on abortion and women’s health in the USA: a systematic review

Review:

Contraception for adolescents with disabilities: taking control of periods, cycles and conditions

Research:

Effects of injectable progestogen contraception versus the copper intrauterine device on HIV acquisition: sub-study of a pragmatic randomised controlled trial

Authors